Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in Rat Hyperoxic Lung Injury

张红珊,方建培,苏浩彬,吴燕云
DOI: https://doi.org/10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2013.0074
2013-01-01
Abstract:【Objective】To investigate the therapeutic effect of bone marrow mesenchymal stem cells(MSC) in hyperoxic lung injury of neonatal rats.【Methods】 Bone marrow MSC cultures were prepared from bone marrow of SD rats by adherent culture,and were transfected by lentiviral vector carrying GFP gene.Newborn rat pups from four different litters were randomized to A,B,C,D,and E groups.Different dose of bone marrow MSC(1 × 105 per pup or 1 × 104 per pup) were injected via the tail vein respectively for A and B groups after 7 days oxygen exposure,and phosphate buffered saline(PBS) for C group.MSCs and PBS were injected respectively for D and E groups as normoxia groups.The engraftment of MSCs in neonatal rat lungs,weight gaining,lung coefficient,radical alveolar counts and lung histology were assessed.【Results】 GFP positive cells were found in rats lungs of A,B,D groups;the ratio of GFP-positive cells in A and B groups were higher than that of D group(31.3±2.6% vs 11.8±1.3%,A group vs D group,22.7 ± 1.3% vs 11.8 ± 1.3%,B group vs D group,P < 0.05);the ratio of A group was also higher than that of B group,P < 0.05).Bone marrow MSC exerted their therapeutic benefit of improving weight gaining(66 ± 9 g vs 48 ± 7 g,A group vs C group,P < 0.05),radical alveolar counts(9.2 ± 0.7 vs 7.4 ± 0.4,A group vs C group,P < 0.05),decreasing lung coefficient(2.26 ± 0.23% vs 2.9 ± 0.4%,A group vs C group,P < 0.05) and suppressing lung inflammation of neonatal rats,and which were significant better in the high dose group of MSCs treatment than that of low dose group.【Conclusion】 Both two doses of bone marrow MSC treatment could attenuate hyperoxia-induced lung injury in newborn rats,and the therapeutic effect of high dose group was more obviously.
What problem does this paper attempt to address?